Clinical Trials Sponsored by Advanced Ophthalmic Pharma

Total 51 results

Advanced Ophthalmic Pharma

Completed

Bioequivalence of Eye Drops and Spray Administration of Vigamox

Cataract

Israel
Advanced Ophthalmic Pharma

Withdrawn

Using Device Delivering Ophthalmic Solution in a Spray Form Instead of Eye Drops

Cataract
Neurotec Pharma
Advancell - Advanced In Vitro Cell Technologies, S.A.

Completed

A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis

Spain, Germany
Sun Pharma Advanced Research Company Limited

Active, not recruiting

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Early Parkinson Disease

United States, Spain, India, Hungary, Slovakia, Poland
Sun Pharma Advanced Research Company Limited

Completed

Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Breast Cancer and Ovarian Cancer
Sun Pharma Advanced Research Company Limited

Withdrawn

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Advanced Biliary Tract Cancer

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

Ovarian Carcinoma

India
Sun Pharma Advanced Research Company Limited

Withdrawn

Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain

Acute Muscle Pain
Sun Pharma Advanced Research Company Limited

Completed

Study of SPARC1103 in Subjects With Spasticity

Spasticity

United States, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer

Recurrent or Metastatic Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Terminated

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Breast Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316

Asthma

United Kingdom
Sun Pharma Advanced Research Company Limited

Terminated

A Study in Patients With Advanced Breast Cancer

Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer

United States, India
Sun Pharma Advanced Research Company Limited

Completed

Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects

Healthy Volunteer Study

United States, Canada
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Withdrawn

To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Recurrent Cancer

India
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC0921 in Subjects With Spasticity

Spasticity

United States, Germany, Hungary, Russian Federation, Ukraine
Sun Pharma Advanced Research Company Limited

Completed

Safety and Efficacy of SPARC1203 in Allergic Rhinitis

Allergic Rhinitis

Germany
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety Study of SPARC1104

Spasticity

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic, Safety and Tolerability Study of SPARC1028

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Sun Pharma Advanced Research Company Limited

Active, not recruiting

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Healthy (For Part A) | Chronic Myeloid Leukemia (for Part B and C)

United States, Spain, Hungary, Italy, India, Belgium, France, Romania, Singapore, United Kingdom, Korea, Republic of, Turkey
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Safety and Efficacy of PDP-716

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Efficacy and Safety of SDN-037

Inflammation and Pain Associated With Ocular Surgery

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 (Study 2) in Healthy Adult Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

A Bioequivalence Study of SPARC_147709 in Patients With Multiple Myeloma

Multiple Myeloma
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of K0706 in Healthy Subjects

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Solid Tumor in Advanced Stage

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of SPARC001 in Healthy Adult Volunteers

Healthy
Sun Pharma Advanced Research Company Limited

Completed

Efficacy and Safety of SPARC1310 in Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Relative Abuse Potential of Hydrocodone Bitartrate and Acetaminophen

Healthy

Canada
Ocuphire Pharma, Inc.
Ophthalmic Consultants of Long Island

Completed

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances (SNV)

Decrease in Night Vision | Disturbance; Vision, Loss

United States
Advanced Research Network
Astellas Pharma US, Inc.

Terminated

VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

Over-Active Bladder

United States
Lallemand Pharma AG
Sprim Advanced Life Sciences

Completed

Advanced Immunological Approach in COPD Exacerbation (AIACE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Georgetown University
Sun Pharma Advanced Research Company Limited

Recruiting

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States
SignPath Pharma, Inc.
Avance Clinical

Recruiting

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

Glioblastoma

United States
Advanz Pharma
AMS Advanced Medical Services GmbH; APCER Life Sciences

Completed

Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases (RETRACE)

Hepatic Insufficiency | Renal Insufficiency | Immunosuppression

Spain, France, Germany, Italy
Pharm-Olam, LLC
Biomedical Advanced Research and Development Authority

Terminated

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents (CoVacSpec)

COVID-19

United States, South Africa, Colombia, Guadeloupe, India, Mexico, Puerto Rico
Correvio International Sarl
PrimeVigilance; AMS Advanced Medical Services GmbH

Terminated

Xydalba Utilization Registry in Germany

Bacterial Infections

Germany
University of Nairobi
Consortium for Advanced Research Training in Africa (CARTA); Innovix Pharma...

Completed

Omega-3 Supplementation and Depression Clinical Trial

Depressive Symptoms

Kenya
SOLTI Breast Cancer Research Group
Merck Sharp & Dohme LLC; Pfizer; AstraZeneca; Astellas Pharma Inc; Advanced Accelerator... and other collaborators

Recruiting

Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) (HOPE-PROSTATE)

Metastatic Prostate Cancer

Spain
Glycovax Pharma Inc.
Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.

Active, not recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

SARS-CoV-2

Australia
University of Ibadan
Shin Poong Pharm Co Ltd 161 yoksam-ro, Gangnam-Gu Seoul 135-925, Korea; Institute...

Completed

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

Plasmodium Falciparum Malaria | Uncomplicated Malaria | Malaria Fever

Nigeria
Elisa María Cubiles Montero de Espinosa
Andalusian Network for Design and Translation of Advanced Therapies

Recruiting

Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.

Cleft Lip and Palate

Spain
University of California, San Francisco
University of Colorado, Denver; University of Maryland; Zhongshan Ophthalmic... and other collaborators

Completed

Ahmed Glaucoma Valve Surgery With Mitomycin-C (AMCT)

Primary Open Angle Glaucoma | Glaucoma | Neovascular Glaucoma | Secondary Glaucoma

United States, China, India, Mexico
PENTA Foundation
Baylor College of Medicine; University Hospital Birmingham NHS Foundation Trust and other collaborators

Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old (D3 (Penta21))

HIV Infections

Spain, United Kingdom, Thailand, South Africa, Uganda

Clinical Trials Sponsored by Advanced Ophthalmic Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations